User:Mr. Ibrahem/Cangrelor

Cangrelor, sold under the brand name Kengreal among others, is a medication used in those undergoing percutaneous coronary intervention (PCI) to prevent blood clots. It is used with aspirin. It is given by injection into a vein.

Common side effects include bleeding and shortness of breath. Other side effects may include allergic reactions. Safety in pregnancy is unclear. It is a P2Y12 inhibitor which blocks platelets from sticking together.

Cangrelor was approved for medical use in the United States and Europe in 2015. In the United Kingdom 50 mg costs the NHS about £250 as of 2021. This amount in the United States costs about 830 USD.